Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders

被引:74
|
作者
Turner, Barbara J. [1 ,2 ,3 ]
Liang, Yuanyuan [2 ,3 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio UTHSCSA, Dept Med, Div Gen Internal Med, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Ctr Res Adv Community Hlth ReACH, San Antonio, TX 78229 USA
[3] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol & Biostat, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
opioid analgesics; overdose; psychotherapeutic drugs; UNITED-STATES; DEATHS; DEPRESSION; MANAGEMENT; MEDICATION; EPIDEMIC; TRENDS; RISK; CARE;
D O I
10.1007/s11606-015-3199-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Opioid analgesics and other psychoactive drugs may pose an even greater risk for drug overdose in persons with mental health disorders. The purpose of this study was to examine interactions of filled prescriptions for opioids, benzodiazepines, antidepressants, and zolpidem with mental health disorders in regard to drug overdose. The study was a retrospective cohort review. Subjects were national HMO beneficiaries aged 18-64 years, enrolled at least 1 year (01/2009 to 07/2012), who filled at least two prescriptions for Schedule II or III opioids for non-cancer pain. The outcome was the first inpatient or outpatient drug overdose after the first filled opioid prescription. Predictors were calculated in 6-month intervals and exactly 6 months before a drug overdose: opioid use (mean daily morphine-equivalent dose), benzodiazepine use (days' supply), antidepressant use (days' supply), zolpidem use (days' supply), mental health disorders (depression, anxiety/PTSD, psychosis), pain-related conditions, and substance use disorders (alcohol, other drug). A total of 1,385 (0.67 %) subjects experienced a drug overdose (incidence rate 421/100,000 person-years). The adjusted odds ratios (AOR) for overdose among all subjects rose monotonically with daily opioid dose, but highest (AOR = 7.06) for persons with depression and a high opioid dose (a parts per thousand yen100 mg) versus no depression or opioid use. Longer-term antidepressants (91-180 days) were protective for persons with depression, with 20 % lower AORs for overdose versus short-term (1-30 days) or none. For persons without depression, the AORs of overdose were increased for antidepressant use, but greatest (AOR = 1.98) for short-term use versus none. The AORs of overdose increased with the duration of benzodiazepine therapy among all subjects, with over 2.5-fold higher AORs for 91-180 days versus none. Opioids and longer-duration benzodiazepines were associated with drug overdose among all subjects, but opioid risk was greatest for persons with depression. Antidepressant use > 90 days reduced the odds of overdose for persons with depression, but all antidepressant use increased the risk for persons without depression.
引用
收藏
页码:1081 / 1096
页数:16
相关论文
共 8 条
  • [1] Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders
    Barbara J. Turner
    Yuanyuan Liang
    [J]. Journal of General Internal Medicine, 2015, 30 : 1081 - 1096
  • [2] Risk of Overdose with Exposure to Prescription Opioids, Benzodiazepines, and Non-benzodiazepine Sedative-Hypnotics in Adults: a Retrospective Cohort Study
    Joanne Cho
    Michele M. Spence
    Fang Niu
    Rita L. Hui
    Patricia Gray
    Steven Steinberg
    [J]. Journal of General Internal Medicine, 2020, 35 : 696 - 703
  • [3] Risk of Overdose with Exposure to Prescription Opioids, Benzodiazepines, and Non-benzodiazepine Sedative-Hypnotics in Adults: a Retrospective Cohort Study
    Cho, Joanne
    Spence, Michele M.
    Niu, Fang
    Hui, Rita L.
    Gray, Patricia
    Steinberg, Steven
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (03) : 696 - 703
  • [4] Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada
    Wilton, James
    Chong, Mei
    Abdia, Younathan
    Purssell, Roy
    MacInnes, Aaron
    Gomes, Tara
    Dart, Richard C.
    Balshaw, Robert F.
    Otterstatter, Michael
    Wong, Stanley
    Yu, Amanda
    Alvarez, Maria
    Janjua, Naveed Zafar
    Buxton, Jane A.
    [J]. BMJ OPEN, 2021, 11 (04):
  • [5] Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study
    Chung, Cecilia P.
    Dupont, William D.
    Murray, Katherine T.
    Hall, Kathi
    Stein, C. Michael
    Ray, Wayne A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (01) : 48 - 53
  • [6] Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study
    Wilton, James
    Abdia, Younathan
    Chong, Mei
    Karim, Mohammad Ehsanul
    Wong, Stanley
    MacInnes, Aaron
    Balshaw, Rob
    Zhao, Bin
    Gomes, Tara
    Yu, Amanda
    Alvarez, Maria
    Dart, Richard C.
    Krajden, Mel
    Buxton, Jane A.
    Janjua, Naveed Z.
    Purssell, Roy
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 375
  • [7] Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study
    Degenhardt, Louisa
    Bruno, Raimondo
    Lintzeris, Nicholas
    Hall, Wayne
    Nielsen, Suzanne
    Larance, Briony
    Cohen, Milton
    Campbell, Gabrielle
    [J]. LANCET PSYCHIATRY, 2015, 2 (04): : 314 - 322
  • [8] COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study
    Tuan, Wen-Jan
    Spotts, Hannah
    Zgierska, Aleksandra E.
    Lennon, Robert P.
    [J]. BMJ OPEN, 2021, 11 (11):